Wnt signaling in cancer stem cells and colon cancer metastasis

F1000Research

Volumn 5, Issue , 2016, Pages

  Ben Ze'ev, Avri ^a   Basu, Sayon ^a   Haase, Gal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; EPHRIN RECEPTOR B2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; RAC1 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR SOX9;

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL SUBPOPULATION; COLORECTAL CANCER; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENE TARGETING; HOMEOSTASIS; HUMAN; INTESTINAL STEM CELL; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOLECULAR INTERACTION; NONHUMAN; REGULATORY MECHANISM; REVIEW; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY;

EID: 84978524240     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.7579.1     Document Type: Review

References (92)

1. Clevers H Loh KM Nusse R: Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science. 2014;346(6205): 1248012. 25278615 10.1126/science.1248012
2. Conacci-Sorrell M Zhurinsky J Ben-Ze'ev A: The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109(8):987-91. 11956233 10.1172/JCI15429 150951
3. Gross JC Chaudhary V Bartscherer K: Active Wnt proteins are secreted on exosomes. Nat Cell Biol. 2012;14(10):1036-45. 22983114 10.1038/ncb2574 F1000 Recommendation
4. Alexandre C Baena-Lopez A Vincent JP: Patterning and growth control by membrane-tethered Wingless. Nature. 2014;505(7482):180-5. 24390349 10.1038/nature12879 F1000 Recommendation
5. Koo BK Spit M Jordens I: Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature. 2012;488(7413):665-9. 22895187 10.1038/nature11308 F1000 Recommendation
6. Hao HX Xie Y Zhang Y: ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature. 2012;485(7397):195-200. 22575959 10.1038/nature11019 F1000 Recommendation
7. Bienz M Clevers H: Linking colorectal cancer to Wnt signaling. Cell. 2000;103(2):311-20. 11057903 10.1016/S0092-8674(00)00122-7
8. Kinzler KW Vogelstein B: Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159-70. 8861899 10.1016/S0092-8674(00)81333-1
9. Gavert N Ben-Ze'ev A: beta-Catenin signaling in biological control and cancer. J Cell Biochem. 2007;102(4):820-8. 17854061 10.1002/jcb.21505
10. Marshman E Booth C Potten CS: The intestinal epithelial stem cell. Bioessays. 2002;24(1):91-8. 11782954 10.1002/bies.10028
11. Gregorieff A Clevers H: Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005;19(8):877-90. 15833914 10.1101/gad.1295405
12. Korinek V Barker N Moerer P: Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19(4):379-83. 9697701 10.1038/1270
13. Pinto D Gregorieff A Begthel H: Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003;17(14):1709-13. 12865297 10.1101/gad.267103 196179 F1000 Recommendation
14. Kuhnert F Davis CR Wang HT: Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci U S A. 2004;101(1):266-71. 14695885 10.1073/pnas.2536800100 314174
15. Ordóñez-Morán P Dafflon C Imajo M: HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer. Cancer Cell. 2015;28(6):815-29. 26678341 10.1016/j.ccell.2015.11.001 F1000 Recommendation
16. Fevr T Robine S Louvard D: Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol. 2007;27(21):7551-9. 17785439 10.1128/MCB.01034-07 2169070
17. van Es JH Haegebarth A Kujala P: A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol Cell Biol. 2012;32(10):1918-27. 22393260 10.1128/MCB.06288-11 3347420 F1000 Recommendation
18. Barker N van Es JH Kuipers J: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003-7. 17934449 10.1038/nature06196 F1000 Recommendation
19. Muñoz J Stange DE Schepers AG: The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J. 2012;31(14):3079-91. 22692129 10.1038/emboj.2012.166 3400017 F1000 Recommendation
20. van der Flier LG van Gijn ME Hatzis P: Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 2009;136(5):903-12. 19269367 10.1016/j.cell.2009.01.031
21. Furuyama K Kawaguchi Y Akiyama H: Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet. 2011;43(1):34-41. 21113154 10.1038/ng.722 F1000 Recommendation
22. Ramalingam S Daughtridge GW Johnston MJ: Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture. Am J Physiol Gastrointest Liver Physiol. 2012;302(1):G10-20. 21995959 10.1152/ajpgi.00277.2011 3345960 F1000 Recommendation
23. Clevers H: The intestinal crypt, a prototype stem cell compartment. Cell. 2013;154(2):274-84. 23870119 10.1016/j.cell.2013.07.004
24. Potten CS Booth C Pritchard DM: The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol. 1997;78(4):219-43. 9505935 10.1046/j.1365-2613.1997.280362.x 2694540
25. Potten CS: Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 1998;353(1370):821-30. 9684279 10.1098/rstb.1998.0246 1692280
26. Potten CS Owen G Booth D: Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci. 2002;115(Pt 11):2381-8. 12006622
27. Sangiorgi E Capecchi MR: Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 2008;40(7):915-20. 18536716 10.1038/ng.165 2906135
28. Yan KS Chia LA Li X: The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci U S A. 2012;109(2):466-71. 22190486 10.1073/pnas.1118857109 3258636 F1000 Recommendation
29. Buczacki SJ Zecchini HI Nicholson AM: Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature. 2013;495(7439):65-9. 23446353 10.1038/nature11965 F1000 Recommendation
30. Montgomery RK Carlone DL Richmond CA: Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A. 2011;108(1):179-84. 21173232 10.1073/pnas.1013004108 3017192 F1000 Recommendation
31. Powell AE Wang Y Li Y: The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell. 2012;149(1):146-58. 22464327 10.1016/j.cell.2012.02.042 3563328 F1000 Recommendation
32. Takeda N Jain R LeBoeuf MR: Interconversion between intestinal stem cell populations in distinct niches. Science. 2011;334(6061):1420-4. 22075725 10.1126/science.1213214 3705713 F1000 Recommendation
33. van Es JH Sato T van de Wetering M: Dll1 + secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol. 2012;14(10):1099-104. 23000963 10.1038/ncb2581 3789123 F1000 Recommendation
34. Vermeulen L Snippert HJ: Stem cell dynamics in homeostasis and cancer of the intestine. Nat Rev Cancer. 2014;14(7):468-80. 24920463 10.1038/nrc3744
35. Gupta PB Chaffer CL Weinberg RA: Cancer stem cells: mirage or reality? Nat Med. 2009;15(9):1010-2. 19734877 10.1038/nm0909-1010
36. Shih IM Wang TL Traverso G: Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A. 2001;98(5):2640-5. 11226292 10.1073/pnas.051629398 30191
37. Preston SL Wong WM Chan AO: Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res. 2003;63(13):3819-25. 12839979
38. Schwitalla S Fingerle AA Cammareri P: Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 2013;152(1-2):25-38. 23273993 10.1016/j.cell.2012.12.012 F1000 Recommendation
39. Cole JW McKalen A: Studies on the morphogenesis of adenomatous polyps in the human colon. Cancer. 1963;16(8):998-1002. 14050018 10.1002/1097-0142(196308)16:8<998::AID-CNCR2820160806>3.0.CO;2-C
40. Barker N Ridgway RA van Es JH: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457(7229):608-11. 19092804 10.1038/nature07602 F1000 Recommendation
41. Dow LE O'Rourke KP Simon J: Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer. Cell. 2015;161(7):1539-52. 26091037 10.1016/j.cell.2015.05.033 4475279 F1000 Recommendation
42. Brabletz T Jung A Reu S: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A. 2001;98(18):10356-61. 11526241 10.1073/pnas.171610498 56965
43. Brabletz T Jung A Hermann K: Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract. 1998;194(10):701-4. 9820866 10.1016/S0344-0338(98)80129-5
44. Jung A Schrauder M Oswald U: The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16 INK4A and is a region of low proliferation. Am J Pathol. 2001;159(5):1613-7. 11696421 10.1016/S0002-9440(10)63007-6 1867079
45. Gavert N Conacci-Sorrell M Gast D: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005;168(4):633-42. 15716380 10.1083/jcb.200408051 2171754
46. Vignjevic D Schoumacher M Gavert N: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 2007;67(14):6844-53. 17638895 10.1158/0008-5472.CAN-07-0929
47. Vermeulen L De Sousa E Melo F van der Heijden M: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12(5):468-76. 20418870 10.1038/ncb2048 F1000 Recommendation
48. Schepers AG Snippert HJ Stange DE: Lineage tracing reveals Lgr5 + stem cell activity in mouse intestinal adenomas. Science. 2012;337(6095):730-5. 22855427 10.1126/science.1224676 F1000 Recommendation
49. Uchida H Yamazaki K Fukuma M: Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci. 2010;101(7):1731-7. 20384634 10.1111/j.1349-7006.2010.01571.x F1000 Recommendation
50. Merlos-Suárez A Barriga FM Jung P: The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011;8(5):511-24. 21419747 10.1016/j.stem.2011.02.020 F1000 Recommendation
51. Kemper K Prasetyanti PR De Lau W: Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells. 2012;30(11):2378-86. 22969042 10.1002/stem.1233 F1000 Recommendation
52. Dalerba P Kalisky T Sahoo D: Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol. 2011;29(12):1120-7. 22081019 10.1038/nbt.2038 3237928 F1000 Recommendation
53. Ziskin JL Dunlap D Yaylaoglu M: In situ validation of an intestinal stem cell signature in colorectal cancer. Gut. 2013;62(7):1012-23. 22637696 10.1136/gutjnl-2011-301195 F1000 Recommendation
54. De Sousa E Melo F Colak S Buikhuisen J: Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell. 2011;9(5):476-85. 22056143 10.1016/j.stem.2011.10.008 F1000 Recommendation
55. Ye X Weinberg RA: Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol. 2015;25(11):675-86. 26437589 10.1016/j.tcb.2015.07.012 4628843
56. Cao H Xu E Liu H: Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract. 2015;211(8):557-69. 26092594 10.1016/j.prp.2015.05.010
57. Zheng X Carstens JL Kim J: Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015;527(7579):525-30. 26560028 10.1038/nature16064 F1000 Recommendation
58. Fischer KR Durrans A Lee S: Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527(7579):472-6. 26560033 10.1038/nature15748 4662610 F1000 Recommendation
59. Fodde R Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19(2):150-8. 17306971 10.1016/j.ceb.2007.02.007
60. Oskarsson T Batlle E Massagué J: Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14(3):306-21. 24607405 10.1016/j.stem.2014.02.002 3998185
61. Stange DE Engel F Longerich T: Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut. 2010;59(9):1236-44. 20479215 10.1136/gut.2009.195701 F1000 Recommendation
62. Shvab A Haase G Ben-Shmuel A: Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression. Oncogene. 2016;35(5):549-57. 25915847 10.1038/onc.2015.127
63. Vaiopoulos AG Athanasoula KC Papavassiliou AG: NF-κB in colorectal cancer. J Mol Med (Berl). 2013;91(9):1029-37. 23636511 10.1007/s00109-013-1045-x
64. Karin M Cao Y Greten FR: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301-10. 12001991 10.1038/nrc780
65. Gavert N Ben-Shmuel A Lemmon V: Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci. 2010;123(Pt 12):2135-43. 20501702 10.1242/jcs.069542 4481617 F1000 Recommendation
66. Ben-Shmuel A Shvab A Gavert N: Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression. Oncogene. 2013;32(27):3220-30. 22869145 10.1038/onc.2012.340
67. Athineos D Sansom OJ: Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine. Oncogene. 2010;29(17):2585-90. 20140021 10.1038/onc.2010.5 F1000 Recommendation
68. Myant KB Cammareri P McGhee EJ: ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell. 2013;12(6):761-73. 23665120 10.1016/j.stem.2013.04.006 3690525 F1000 Recommendation
69. Hanahan D Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. 21376230 10.1016/j.cell.2011.02.013 F1000 Recommendation
70. Quante M Varga J Wang TC: The gastrointestinal tumor microenvironment. Gastroenterology. 2013;145(1):63-78. 23583733 10.1053/j.gastro.2013.03.052 4012393
71. Hardwick JC Kodach LL Offerhaus GJ: Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer. 2008;8(10):806-12. 18756288 10.1038/nrc2467
72. Drost J van Jaarsveld RH Ponsioen B: Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521(7550):43-7. 25924068 10.1038/nature14415 F1000 Recommendation
73. Grady WM Markowitz SD: Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet. 2002;3:101-28. 12142355 10.1146/annurev.genom.3.022502.103043
74. Kim JS Crooks H Dracheva T: Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res. 2002;62(10):2744-8. 12019147
75. van de Wetering M Sancho E Verweij C: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111(2):241-50. 12408868 10.1016/S0092-8674(02)01014-0 F1000 Recommendation
76. Whissell G Montagni E Martinelli P: The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression. Nat Cell Biol. 2014;16(7):695-707. 24952462 10.1038/ncb2992 F1000 Recommendation
77. Voorneveld PW Kodach LL Jacobs RJ: The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC. Br J Cancer. 2015;112(1):122-30. 25393365 10.1038/bjc.2014.560 4453609 F1000 Recommendation
78. Ragusa S Cheng J Ivanov KI: PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt (high) metastatic colon cancer cells. Cell Rep. 2014;8(6):1957-73. 25242332 10.1016/j.celrep.2014.08.041 F1000 Recommendation
79. Wiener Z Högström J Hyvönen V: Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance. Cell Rep. 2014;8(6):1943-56. 25242330 10.1016/j.celrep.2014.08.034 F1000 Recommendation
80. Shapiro B Tocci P Haase G: Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis. Oncotarget. 2015;6(33):34389-401. 26399194 10.18632/oncotarget.5360 4741460
81. Potten CS Booth C Tudor GL: Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation. 2003;71(1):28-41. 12558601 10.1046/j.1432-0436.2003.700603.x
82. Fan LF Dong WG Jiang CQ: Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis. 2010;25(1):17-23. 19714342 10.1007/s00384-009-0791-2 F1000 Recommendation
83. Li D Peng X Yan D: Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol. 2011;18(7):2074-83. 21442350 10.1245/s10434-011-1567-9 F1000 Recommendation
84. Rezza A Skah S Roche C: The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci. 2010;123(Pt 19):3256-65. 20826465 10.1242/jcs.065284 F1000 Recommendation
85. Wang S Li N Yousefi M: Transformation of the intestinal epithelium by the MSI2 RNA-binding protein. Nat Commun. 2015;6:6517. 25774828 10.1038/ncomms7517 4643281 F1000 Recommendation
86. Takebe N Ivy SP: Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res. 2010;16(12):3106-12. 20530695 10.1158/1078-0432.CCR-09-2934
87. Leedham SJ Wright NA: Expansion of a mutated clone: from stem cell to tumour. J Clin Pathol. 2008;61(2):164-71. 17468295 10.1136/jcp.2006.044610
88. Novelli MR Williamson JA Tomlinson IP: Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science. 1996;272(5265):1187-90. 8638166 10.1126/science.272.5265.1187
89. Merritt AJ Gould KA Dove WF: Polyclonal structure of intestinal adenomas in Apc Min/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc Natl Acad Sci U S A. 1997;94(25):13927-31. 9391129 10.1073/pnas.94.25.13927 28409
90. He S Zhou H Zhu X: Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. Biomed Pharmacother. 2014;68(5):507-13. 24751002 10.1016/j.biopha.2014.03.016 F1000 Recommendation
91. Takeda K Kinoshita I Shimizu Y: Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res. 2011;31(1):263-70. 21273608 F1000 Recommendation
92. Wu XS Xi HQ Chen L: Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol. 2012;10:244. 23153436 10.1186/1477-7819-10-244 3506563 F1000 Recommendation